BIS range and propofol depth during total IV anesthesia with adjuvants for knee replacement
Official title: A Prospective, Randomized Study to Determine the Appropriate Bispectral Index Range and Propofol Effect-Site Concentration During Total Intravenous Anesthesia Combined With Midazolam, Dexmedetomidine or Esketamine.
Run by China-Japan Friendship Hospital · NCT07736352 · Data updated 2026-11-12
This study tests the right BIS range and propofol level to keep anesthesia deep enough when using propofol with midazolam, dexmedetomidine, or esketamine in knee replacement patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | July 30, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT07736352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-65 years with ASA I-II status undergoing elective unilateral total knee replacement, able to consent and comply with procedures.
✕Probably not a fit
Patients with neurological conditions, cognitive impairment, significant cardiovascular issues, or allergy to intravenous anesthetics may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to define the appropriate Bispectral Index (BIS) range and propofol effect-site concentration to maintain adequate anesthesia depth during total intravenous anesthesia (TIVA) when combined with either midazolam, dexmedetomidine, or esketamine in adults undergoing unilateral knee replacement. Participants are assigned to one of four regimens: propofol alone, or propofol with one of the three adjuvants, with a stepwise reduction of propofol near the end of surgery to assess recovery quality and postoperative pain. Outcomes focus on anesthesia depth control, recovery quality, and pain after surgery. The trial will be conducted at China-Japan Friendship Hospital in Beijing, with ASA I-II adults aged 18-65.
Why it matters
Potential benefit: If successful, it could help tailor anesthesia depth and drug combinations to improve recovery and pain control after knee replacement.
How similar studies have gone: Prior research has explored BIS guidance and adjuvant use in TIVA, but this specific combination with midazolam, dexmedetomidine, or esketamine for knee replacement is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 65 years * American Society of Anesthesiologists (ASA) physical status I or II * Body Mass Index (BMI) 18 to 30 kg/m² * Scheduled for elective unilateral total knee replacement surgery * Willing to participate in the study and signed informed consent form, and able to comply with the intervention and assessment procedures Exclusion Criteria: * History of neurological disorders * Cognitive dysfunction assessed by the Mini-Cog scale * History of antipsychotic or sedative medication use in the past 4 weeks * Poorly controlled or untreated hypertension * Sinus bradycardia, cardiac conduction block, or severe heart failure * Acute angle-closure glaucoma * Allergic to intravenous anesthetics * Hearing impairment, could not cooperate in intervention and evaluation * Contraindications to tourniquet use on the upper arm
Where it's running
-
China-Japan Friendship Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Ma
- Email: maye_1316@163.com
- Phone: +86-10-84205882
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.